cAMP
Athanor · official
C10H12N5O6P · 329.21 g/mol
IUPAC name: (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
Also called cyclic AMP, adenosine 3',5'-cyclic monophosphate, second messenger
Names and identifiers
- IUPAC name
- (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
- Synonyms
- cyclic AMP, adenosine 3',5'-cyclic monophosphate, second messenger
+ 38 more
Cyclic AMP, Adenosine 3',5'-cyclic monophosphate, 3',5'-cyclic AMP, Adenosine 3',5'-cyclophosphate, cyclic 3',5'-AMP, Adenosine 3',5'-phosphate, Cyclic Adenosine Monophosphate, Adenosine cyclic monophosphate, cyclic 3',5'-Adenylic acid, Adenosine 3',5'-monophosphate, cyclic Adenosine 3',5'-phosphate, Adenosine cyclic 3',5'-monophosphate, Adenosine, cyclic 3',5'-(hydrogen phosphate), Adenosine 3',5'-cyclic phosphate, 3',5'-AMP, Adenosine cyclic 3',5'-phosphate, Adenosine cyclic phosphate, Cyclic adenylic acid, DTXSID8040436, Cyclic Monophosphate, Adenosine, E0399OZS9N, (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol, CHEBI:17489, Adenosine Cyclic 3',5' Monophosphate, DTXCID6020436, NSC-143670, Adenosine cyclic 3',5'-(hydrogen phosphate), adenosine cyclic-3',5'-monophosphate, 3',5'-Monophosphate, Adenosine Cyclic, NSC-94017, AMP, Cyclic, (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo[3,2-d][1,3,2$l^{5}]dioxaphosphinin-2-one, (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one, Monophosphate, Adenosine Cyclic, (1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^(5)-phosphabicyclo(4.3.0)nonan-9-ol, (1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol, (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^(5)-furo(3,2-d)(1,3,2$l^(5))dioxaphosphinin-2-one, (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo(3,2-d)(1,3,2)dioxaphosphinin-2-one
- Molecular formula
- C10H12N5O6P
- Empirical formula
- C10H12N5O6P
- Molecular weight
- 329.21 g/mol
- Exact mass
- 329.05252
- CAS number
- 60-92-4
- PubChem CID
- 6076
- Canonical SMILES
- C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O
- Isomeric SMILES
- C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O
- InChI
- InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
- InChIKey
- IVOMOUWHDPKRLL-KQYNXXCUSA-N
- Molfile
Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.
Calculated
- Heavy atoms
- 22
- Rings
- 4
- Aromatic rings
- 2
- Fraction sp³ carbons (Fsp3)
- 0.5
- H-bond donors
- 3
- H-bond acceptors
- 9 computed here · PubChem 10
- Rotatable bonds
- 1
- TPSA (Ų)
- 154.8 computed here · PubChem 155
- Formal charge
- 0
- XLogP3
- -2.6 PubChem
- Complexity
- 498 PubChem
- Stereocenters
- 4 defined, 1 undefinedCIP: C11: R · C13: R · P16: undefined · C20: S · C21: R
- Double-bond geometry
- None specified
- Point group
- C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)
Elemental analysis
- C36.48%
- H3.67%
- N21.27%
- O29.16%
- P9.41%
Isotope pattern
Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.
Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.
Predicted
- log P
- -0.82 Crippen (Wildman and Crippen 1999)
- log S (water solubility)
- -1.6 ESOL (Delaney 2004), log mol/L
- Synthetic accessibility
- 4.35 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)
Drug-likeness: Lipinski’s rule of five
- Molecular weight ≤ 500: 329.21
- log P ≤ 5 (Crippen): -0.82
- H-bond donors ≤ 5: 3
- H-bond acceptors ≤ 10: 9
Passes all four rules.
¹³C NMR shifts, predicted
Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.
Safety
Danger
Most widely reported: 6 company reports to ECHA. Source [1].
Corrosive
Harmful or irritant
- H314Causes severe skin burns and eye damage (16.7% of reports)
- H315Causes skin irritation (50% of reports)
- H318Causes serious eye damage (16.7% of reports)
- H319Causes serious eye irritation (50% of reports)
- H335May cause respiratory irritation (50% of reports)
Precautionary statements: P260, P261, P264, P264+P265, P271, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, P501
View all classifications (2)
- [1] European Chemicals Agency (ECHA)This chemical does not meet GHS hazard criteria for 33.3% (2 of 6) of reports.
- [1] European Chemicals Agency (ECHA) · 6 reports · DangerH314, H315, H318, H319, H335
Safety data sheets on the supplier’s page: Alfa Chemistry, SynHet - Synthetic Heterocycles, Angene Chemical.
Always read the supplier’s safety data sheet before working with it.
Spectra
- 1H NMRHuman Metabolome Database (HMDB) (Varian · 600 MHz · Water) · Human Metabolome Database (HMDB) (Bruker · D2O) · SpectraBase
- 13C NMRHuman Metabolome Database (HMDB) (Bruker · D2O) · SpectraBase
- 31P NMRSpectraBase (Bruker HX-90)
- 1H-1H NMRHuman Metabolome Database (HMDB)
- 1H-13C NMRHuman Metabolome Database (HMDB) (Bruker · 600 MHz · Water)
- GC-MSHuman Metabolome Database (HMDB) (GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) · Positive) · Human Metabolome Database (HMDB) (GC-EI-TOF · positive) · Human Metabolome Database (HMDB) (GC-MS) · MassBank Europe (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies · GC-EI-TOF · POSITIVE) · MassBank of North America (MoNA) (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies · GC-EI-TOF · positive) · MassBank of North America (MoNA) (GC-MS)
- MS-MSHuman Metabolome Database (HMDB) (Positive) · Human Metabolome Database (HMDB) (Positive) · Human Metabolome Database (HMDB) (Positive) · Human Metabolome Database (HMDB) (Positive) · Human Metabolome Database (HMDB) (Positive) · Human Metabolome Database (HMDB) (Positive)
- LC-MSMassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE) · MassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE) · MassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE) · MassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE) · MassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE) · MassBank Europe (Thermo Scientific Q-Exactive Focus · LC-ESI-ITFT · POSITIVE)
- Other MSMassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI) · MassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI) · MassBank of North America (MoNA) (TQD, Waters · Flow-injection QqQ/MS · ESI)
- ATR-IRSpectraBase (Bio-Rad FTS · ATR-Neat (DuraSamplIR II))
Experimental spectra held by these sources; each link opens the source's own record.
Literature
Reading PubChem, OpenAlex and GSRS…
Bioactivity
Reading ChEMBL…
References
- [1]European Chemicals Agency (ECHA) · ECHA legal notice: reuse with acknowledgement · via PubChem · retrieved 2026-10-14
- [2]Human Metabolome Database (HMDB) · Linked only · via PubChem · retrieved 2026-10-14
- [3]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
- [4]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
- [5]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
- [6]NIST Mass Spectrometry Data Center · Linked only · via PubChem · retrieved 2026-10-14
- ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
- ·Literature on PubChem
Data last updated 2026-10-14.
